Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA.
Thyroid. 2010 Nov;20(11):1279-83. doi: 10.1089/thy.2010.0047. Epub 2010 Oct 18.
It is believed that patients who undergo thyroidectomy for Graves' disease are more likely to experience postoperative hypocalcemia than patients undergoing total thyroidectomy for other indications. However, no study has directly compared these two groups of patients. The aim of this study was to determine whether there was an increased incidence or severity of postoperative hypocalcemia in patients who underwent thyroidectomy for Graves' disease.
An institutional review board-approved database was created of all patients who underwent thyroidectomy from 1998 to 2009 at the Johns Hopkins Hospital. There were a total of 68 patients with Graves' disease who underwent surgery. Fifty-five patients who underwent total thyroidectomy were randomly selected and served as control subjects. An analysis was conducted that examined potential covariates for postoperative hypocalcemia, including age, gender, ethnicity, preoperative alkaline phosphatase level, size of goiter, whether parathyroid tissue or glands were present in the specimen, and the reason the patient underwent surgery. Specific outcomes examined were calcium levels on postoperative day 1, whether or not patients experienced symptoms of hypocalcemia, whether or not Rocaltrol was required, the number of calcium tablets prescribed upon discharge, whether or not postoperative tetany occurred, and calcium levels 1 month after discharge.
Each outcome was analyzed using a logistic regression. Graves' disease patients had a significantly (p-value < 0.001) higher odds of greater number of calcium tablets prescribed upon discharge. Further, 6 of 68 patients with Graves' disease and no patient in the control group were readmitted with tetany (p = 0.033). There was a trend, though not significant, toward patients with Graves' disease having a higher prevalence of hypocalcemia the day after thyroidectomy and 1 month later.
Patients with Graves' disease are more likely to require increased dosages of calcium as well as experience tetany postoperatively than patients undergoing total thyroidectomy for other indications. This suggests that patients operated upon for Graves' disease warrant close followup as both inpatients and outpatients for signs and symptoms of hypocalcemia.
据信,因格雷夫斯病而行甲状腺切除术的患者比因其他指征行甲状腺全切除术的患者更容易发生术后低钙血症。然而,尚无研究直接比较这两组患者。本研究旨在确定因格雷夫斯病而行甲状腺切除术的患者是否存在术后低钙血症发生率或严重程度增加的情况。
我们创建了一个经机构审查委员会批准的数据库,其中包含了 1998 年至 2009 年在约翰霍普金斯医院行甲状腺切除术的所有患者。共有 68 例格雷夫斯病患者接受了手术。随机选择了 55 例行甲状腺全切除术的患者作为对照组。我们进行了一项分析,以检查术后低钙血症的潜在协变量,包括年龄、性别、种族、术前碱性磷酸酶水平、甲状腺肿大小、标本中是否存在甲状旁腺组织或腺体,以及患者行手术的原因。我们检查的具体结果包括术后第 1 天的血钙水平、患者是否出现低钙血症症状、是否需要罗盖全、出院时开的钙片数量、是否发生术后手足搐搦以及出院后 1 个月的血钙水平。
我们使用逻辑回归分析了每个结果。格雷夫斯病患者出院时需要更多钙片的可能性显著(p 值<0.001)更高。此外,68 例格雷夫斯病患者中有 6 例和对照组无一例患者因手足搐搦而再次入院(p=0.033)。虽然没有统计学意义,但格雷夫斯病患者术后第 2 天和 1 个月后低钙血症的患病率有升高的趋势。
与因其他指征行甲状腺全切除术的患者相比,因格雷夫斯病而行甲状腺切除术的患者术后更有可能需要增加钙的剂量,并且更容易发生手足搐搦。这表明,因格雷夫斯病而行甲状腺切除术的患者需要作为住院患者和门诊患者密切随访,以发现低钙血症的症状和体征。